DARZALEX 400 MG/20 ML CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION - Turkey License 5fb28b2fe6f9e23519905a7b2ed46488

Access comprehensive regulatory information for DARZALEX 400 MG/20 ML CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 5fb28b2fe6f9e23519905a7b2ed46488 with license number 2017/958and contains active ingredient daratumumab. The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.